CVR Medical Corp.
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system.
The Carotid Stenotic Scan (CSS) is a screening tool designed to detect and measure carotid arterial stenosis or occlusion for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). CVR's screening device is non-emissive, non-invasive, does not require a certified technician, can be conducted in a few minutes, and has a per scan price point that is significantly advantageous as an initial screening tool when compared to the resource requirement associated with other technologies.
CVR's technology makes a connection between fluid flow and sub-sonic frequencies in order to determine the presence of arterial disease/blockage. The technology, in its present configuration, detects and analyzes the low frequency vibrations that radiate passively from the carotid arteries. Blood flowing through the carotid arteries produces wave patterns which are shaped and altered by the presence of any irregularities on the inner walls of those arteries. The wave patterns are captured and mathematically analyzed through CVR's patented algorithms which generate an accurate percentage range of stenosis (including 100% stenosis, or complete occlusion). This analysis is then followed by immediate interpretation with details concerning the inner surface of the carotid arteries against which there is blood flow.
Features & Benefits
Game Changing Technology
East to Use
CVR Medical Corp.
LEADERSHIP / VISION / EXECUTION
Peter Bakema, President, CEO & Chairman of Board
Successful 30 years track record of creating and developing businesses
Chairman & CEO of CVR Global Inc. since inception
Expertise related to rapid growth and scalability
Developed CVR Global organizational structure and know-how from ground up
Michael Rhodes, Vice President of Quality Systems
20 years of Quality Know-how
Former Vice President of Quality for HSBC & Motorola
Experience in multiple markets including healthcare, defense, public safety, retail, energy, and manufacturing
Tony Robinson, COO & Executive Vice President
Global & domestic medical device expertise within Operational, Marketing, Regulatory, M&A, and Financial areas of healthcare
Joined CVR Global Inc. in 2009
Erwin Wong, CA, CFO & Director
Former director of Asian operations for a national institutional brokerage house, and Vice-President of Finance for a publicly-listed Asian based group
Was a director for various Mainland Chinese based enterprises
Dr. W. Douglas Weaver, Director and Scientific Advisory Board
Past President of the American College of Cardiology
Former Vice President and System Medical Director of Heart and Vascular Services at Henry Ford Health System
Over 330 publications, most of which are related to drug and device discovery and methods toward improving the care provided to patients with cardiovascular disease
SCIENCE & ADVISORY
Dr. Orville Day, Lead Physicist
Integral in the original development of the Carotid Stenotic Scan
Specialty: Atomic & Molecular Physics
Tenured Professor at East Carolina University, previously teaching at multiple universities
Dr. Young Truong, Lead Biostatistician
Professor at the University of North Carolina – Chapel Hill
Ph.D. from the University of California-Berkeley, Department of Statistics
Written over 50 publications, including multiple books on statistical analysis
Jim Finlayson, Electronics & Software Engineer
30 years experience
Developed varying military & civilian software and hardware applications, specifically laser guidance, wireless systems, and aerospace instrumentation
Developed weapons systems software for General Atomics Aeronautical Systems
On June 29, 2017, CVR Medical Corp. announced that Thomas Jefferson University Hospital – Jefferson Clinical Research Institute has issued an initial trial report, summarizing the clinical trial progress of the Carotid Stenotic Scan (CSS) under the supervision of Principal Investigator Dr. David Whellan. To view the full report, please visit CVR Medical's website.